Generic Drug Market Report

Europe Generic Drug Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 20, 2020
  • PAGES：236
  • REPORT CODE：GMM569678
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Generic Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Generic Drug Market Segmentations:

    By Player:

    • Novartis company

    • Allergan

    • Aspen Pharmacare

    • Stada

    • Lupin

    • Hospira

    • Mylan

    • Sun Pharmaceutical

    • Fresenius

    • Greenstone

    • Par Pharma

    By Type:

    • Pure (Non-branded) Generics

    • Branded Generics

    • Super Generics

    By End-User:

    • Cardiovascular & Hypertension

    • Dermatology

    • Diabetes

    • Rheumatology

    • Oncology

    • Gastrointestinal

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Generic Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Generic Drug Market Size and Growth Rate of Pure (Non-branded) Generics from 2014 to 2026

    • 1.3.2 Europe Generic Drug Market Size and Growth Rate of Branded Generics from 2014 to 2026

    • 1.3.3 Europe Generic Drug Market Size and Growth Rate of Super Generics from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Generic Drug Market Size and Growth Rate of Cardiovascular & Hypertension from 2014 to 2026

    • 1.4.2 Europe Generic Drug Market Size and Growth Rate of Dermatology from 2014 to 2026

    • 1.4.3 Europe Generic Drug Market Size and Growth Rate of Diabetes from 2014 to 2026

    • 1.4.4 Europe Generic Drug Market Size and Growth Rate of Rheumatology from 2014 to 2026

    • 1.4.5 Europe Generic Drug Market Size and Growth Rate of Oncology from 2014 to 2026

    • 1.4.6 Europe Generic Drug Market Size and Growth Rate of Gastrointestinal from 2014 to 2026

    • 1.4.7 Europe Generic Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Generic Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Generic Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Generic Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Generic Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Generic Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Generic Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Generic Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Generic Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Generic Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Generic Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Generic Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Pure (Non-branded) Generics

      • 3.4.2 Market Size and Growth Rate of Branded Generics

      • 3.4.3 Market Size and Growth Rate of Super Generics

    4 Segmentation of Generic Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Generic Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Cardiovascular & Hypertension for Construction

      • 4.4.2 Market Size and Growth Rate of Dermatology for Construction

      • 4.4.3 Market Size and Growth Rate of Diabetes for Construction

      • 4.4.4 Market Size and Growth Rate of Rheumatology for Construction

      • 4.4.5 Market Size and Growth Rate of Oncology for Construction

      • 4.4.6 Market Size and Growth Rate of Gastrointestinal for Construction

      • 4.4.7 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Generic Drug Production Analysis by Top Regions

    • 5.2 Europe Generic Drug Consumption Analysis by Top Regions

    • 5.3 Europe Generic Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Generic Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Generic Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 France Generic Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Generic Drug Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Generic Drug Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Generic Drug Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Generic Drug Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Generic Drug Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Generic Drug Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of Generic Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in Generic Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Generic Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Generic Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Generic Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Generic Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Generic Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Generic Drug Landscape Analysis

    • 7.1 Germany Generic Drug Landscape Analysis by Major Types

    • 7.2 Germany Generic Drug Landscape Analysis by Major End-Users

    8. UK Generic Drug Landscape Analysis

    • 8.1 UK Generic Drug Landscape Analysis by Major Types

    • 8.2 UK Generic Drug Landscape Analysis by Major End-Users

    9. France Generic Drug Landscape Analysis

    • 9.1 France Generic Drug Landscape Analysis by Major Types

    • 9.2 France Generic Drug Landscape Analysis by Major End-Users

    10. Italy Generic Drug Landscape Analysis

    • 10.1 Italy Generic Drug Landscape Analysis by Major Types

    • 10.2 Italy Generic Drug Landscape Analysis by Major End-Users

    11. Spain Generic Drug Landscape Analysis

    • 11.1 Spain Generic Drug Landscape Analysis by Major Types

    • 11.2 Spain Generic Drug Landscape Analysis by Major End-Users

    12. Poland Generic Drug Landscape Analysis

    • 12.1 Poland Generic Drug Landscape Analysis by Major Types

    • 12.2 Poland Generic Drug Landscape Analysis by Major End-Users

    13. Russia Generic Drug Landscape Analysis

    • 13.1 Russia Generic Drug Landscape Analysis by Major Types

    • 13.2 Russia Generic Drug Landscape Analysis by Major End-Users

    14. Switzerland Generic Drug Landscape Analysis

    • 14.1 Switzerland Generic Drug Landscape Analysis by Major Types

    • 14.2 Switzerland Generic Drug Landscape Analysis by Major End-Users

    15. Turkey Generic Drug Landscape Analysis

    • 15.1 Turkey Generic Drug Landscape Analysis by Major Types

    • 15.2 Turkey Generic Drug Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Landscape Analysis by Top Countries

      • 16.3.1 Denmark Generic Drug Market Volume and Growth Rate

      • 16.3.2 Finland Generic Drug Market Volume and Growth Rate

      • 16.3.3 Norway Generic Drug Market Volume and Growth Rate

      • 16.3.4 Sweden Generic Drug Market Volume and Growth Rate

      • 16.3.6 Iceland Generic Drug Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Landscape Analysis by Top Countries

      • 17.3.1 Belgium Generic Drug Market Volume and Growth Rate

      • 17.3.2 Netherlands Generic Drug Market Volume and Growth Rate

      • 17.3.3 Luxembourg Generic Drug Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Landscape Analysis by Top Countries

      • 18.3.1 Estonia Generic Drug Market Volume and Growth Rate

      • 18.3.2 Latvia Generic Drug Market Volume and Growth Rate

      • 18.3.3 Lithuania Generic Drug Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Novartis company

      • 19.1.1 Novartis company Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Allergan

      • 19.2.1 Allergan Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Aspen Pharmacare

      • 19.3.1 Aspen Pharmacare Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Stada

      • 19.4.1 Stada Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Lupin

      • 19.5.1 Lupin Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Hospira

      • 19.6.1 Hospira Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Mylan

      • 19.7.1 Mylan Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Sun Pharmaceutical

      • 19.8.1 Sun Pharmaceutical Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Fresenius

      • 19.9.1 Fresenius Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Greenstone

      • 19.10.1 Greenstone Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Par Pharma

      • 19.11.1 Par Pharma Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    The List of Tables and Figures (Totals 93 Figures and 162 Tables)

    • Figure Product Picture

    • Figure Generic Drug Market Size and Growth Rate of Pure (Non-branded) Generics Market, 2015 - 2026 (USD Million)

    • Figure Generic Drug Market Size and Growth Rate of Branded Generics Market, 2015 - 2026 (USD Million)

    • Figure Generic Drug Market Size and Growth Rate of Super Generics Market, 2015 - 2026 (USD Million)

    • Figure Generic Drug Market Size and Growth Rate of Cardiovascular & Hypertension from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Dermatology from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Diabetes from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Rheumatology from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Gastrointestinal from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Generic Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Generic Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Generic Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Generic Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Generic Drug by Different Types from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Pure (Non-branded) Generics Market, 2015 - 2026 (USD Million)

    • Figure Generic Drug Market Size and Growth Rate of Branded Generics Market, 2015 - 2026 (USD Million)

    • Figure Generic Drug Market Size and Growth Rate of Super Generics Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Generic Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Generic Drug by Different End-Users from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Cardiovascular & Hypertension from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Dermatology from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Diabetes from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Rheumatology from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Gastrointestinal from 2014 to 2026

    • Figure Generic Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Generic Drug Production by Major Regions

    • Table Europe Generic Drug Production Share by Major Regions

    • Figure Europe Generic Drug Production Share by Major Countries and Regions in 2014

    • Table Europe Generic Drug Consumption by Major Regions

    • Table Europe Generic Drug Consumption Share by Major Regions

    • Table Germany Generic Drug Production, Import, Consumption and Export Analysis

    • Table UK Generic Drug Production, Import, Consumption and Export Analysis

    • Table France Generic Drug Production, Import, Consumption and Export Analysis

    • Table Italy Generic Drug Production, Import, Consumption and Export Analysis

    • Table Spain Generic Drug Production, Import, Consumption and Export Analysis

    • Table Poland Generic Drug Production, Import, Consumption and Export Analysis

    • Table Russia Generic Drug Production, Import, Consumption and Export Analysis

    • Table Switzerland Generic Drug Production, Import, Consumption and Export Analysis

    • Table Turkey Generic Drug Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Generic Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Generic Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Generic Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Generic Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Generic Drug Consumption by Types from 2014 to 2026

    • Table Germany Generic Drug Consumption Share by Types from 2014 to 2026

    • Table Germany Generic Drug Consumption by End-Users from 2014 to 2026

    • Table Germany Generic Drug Consumption Share by End-Users from 2014 to 2026

    • Table UK Generic Drug Consumption by Types from 2014 to 2026

    • Table UK Generic Drug Consumption Share by Types from 2014 to 2026

    • Table UK Generic Drug Consumption by End-Users from 2014 to 2026

    • Table UK Generic Drug Consumption Share by End-Users from 2014 to 2026

    • Table France Generic Drug Consumption by Types from 2014 to 2026

    • Table France Generic Drug Consumption Share by Types from 2014 to 2026

    • Table France Generic Drug Consumption by End-Users from 2014 to 2026

    • Table France Generic Drug Consumption Share by End-Users from 2014 to 2026

    • Table Italy Generic Drug Consumption by Types from 2014 to 2026

    • Table Italy Generic Drug Consumption Share by Types from 2014 to 2026

    • Table Italy Generic Drug Consumption by End-Users from 2014 to 2026

    • Table Italy Generic Drug Consumption Share by End-Users from 2014 to 2026

    • Table Spain Generic Drug Consumption by Types from 2014 to 2026

    • Table Spain Generic Drug Consumption Share by Types from 2014 to 2026

    • Table Spain Generic Drug Consumption by End-Users from 2014 to 2026

    • Table Spain Generic Drug Consumption Share by End-Users from 2014 to 2026

    • Table Poland Generic Drug Consumption by Types from 2014 to 2026

    • Table Poland Generic Drug Consumption Share by Types from 2014 to 2026

    • Table Poland Generic Drug Consumption by End-Users from 2014 to 2026

    • Table Poland Generic Drug Consumption Share by End-Users from 2014 to 2026

    • Table Russia Generic Drug Consumption by Types from 2014 to 2026

    • Table Russia Generic Drug Consumption Share by Types from 2014 to 2026

    • Table Russia Generic Drug Consumption by End-Users from 2014 to 2026

    • Table Russia Generic Drug Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Generic Drug Consumption by Types from 2014 to 2026

    • Table Switzerland Generic Drug Consumption Share by Types from 2014 to 2026

    • Table Switzerland Generic Drug Consumption by End-Users from 2014 to 2026

    • Table Switzerland Generic Drug Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Generic Drug Consumption by Types from 2014 to 2026

    • Table Turkey Generic Drug Consumption Share by Types from 2014 to 2026

    • Table Turkey Generic Drug Consumption by End-Users from 2014 to 2026

    • Table Turkey Generic Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Generic Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Generic Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Generic Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Generic Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Generic Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Generic Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Generic Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Generic Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Generic Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Generic Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Generic Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Generic Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Generic Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Generic Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Novartis company Profiles

    • Table Novartis company Production, Value, Price, Gross Margin 2014-2019

    • Table Novartis company Product benchmarking

    • Table Novartis company Strategic initiatives

    • Table Novartis company SWOT analysis

    • Table Allergan Profiles

    • Table Allergan Production, Value, Price, Gross Margin 2014-2019

    • Table Allergan Product benchmarking

    • Table Allergan Strategic initiatives

    • Table Allergan SWOT analysis

    • Table Aspen Pharmacare Profiles

    • Table Aspen Pharmacare Production, Value, Price, Gross Margin 2014-2019

    • Table Aspen Pharmacare Product benchmarking

    • Table Aspen Pharmacare Strategic initiatives

    • Table Aspen Pharmacare SWOT analysis

    • Table Stada Profiles

    • Table Stada Production, Value, Price, Gross Margin 2014-2019

    • Table Stada Product benchmarking

    • Table Stada Strategic initiatives

    • Table Stada SWOT analysis

    • Table Lupin Profiles

    • Table Lupin Production, Value, Price, Gross Margin 2014-2019

    • Table Lupin Product benchmarking

    • Table Lupin Strategic initiatives

    • Table Lupin SWOT analysis

    • Table Hospira Profiles

    • Table Hospira Production, Value, Price, Gross Margin 2014-2019

    • Table Hospira Product benchmarking

    • Table Hospira Strategic initiatives

    • Table Hospira SWOT analysis

    • Table Mylan Profiles

    • Table Mylan Production, Value, Price, Gross Margin 2014-2019

    • Table Mylan Product benchmarking

    • Table Mylan Strategic initiatives

    • Table Mylan SWOT analysis

    • Table Sun Pharmaceutical Profiles

    • Table Sun Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table Sun Pharmaceutical Product benchmarking

    • Table Sun Pharmaceutical Strategic initiatives

    • Table Sun Pharmaceutical SWOT analysis

    • Table Fresenius Profiles

    • Table Fresenius Production, Value, Price, Gross Margin 2014-2019

    • Table Fresenius Product benchmarking

    • Table Fresenius Strategic initiatives

    • Table Fresenius SWOT analysis

    • Table Greenstone Profiles

    • Table Greenstone Production, Value, Price, Gross Margin 2014-2019

    • Table Greenstone Product benchmarking

    • Table Greenstone Strategic initiatives

    • Table Greenstone SWOT analysis

    • Table Par Pharma Profiles

    • Table Par Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Par Pharma Product benchmarking

    • Table Par Pharma Strategic initiatives

    • Table Par Pharma SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US